Maleki Rad Mahboubeh, Haddad Mahboubeh, Sheybani Fereshte, Shirazinia Matin, Dadgarmoghaddam Maliheh
Department of Infectious Diseases and Tropical Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Trop Med Health. 2025 Apr 24;53(1):58. doi: 10.1186/s41182-025-00738-0.
This study aimed to assess the clinical characteristics, diagnostic certainty, outcomes, and predictors of mortality in patients diagnosed with tuberculous meningitis (TBM), using the Lancet scoring system for diagnostic certainty.
A retrospective cohort was conducted on 100 patients diagnosed with TBM. Patients were classified based on the Lancet scoring system into definite, probable, and possible TBM categories. Clinical features, neuroimaging findings, cerebrospinal fluid (CSF) analysis, and outcomes were analyzed.
The median age of patients was 36.5 years, with 57.0% male. The most common symptoms were fever (64.7%), headache (63.6%), and altered consciousness (60.0%). Hydrocephalus was present in 40.0% of cases. Diagnosis certainty was classified as possible (63.0%), probable (22.0%), and definite (15.0%). The in-hospital mortality rate was 18.0%, with 12-month survival rates of 69.7%. There was no significant difference between the level of diagnostic certainty and the survival of patients. Significant predictors of mortality included hydrocephalus (hazard ratio [HR]: 3.65, 95% CI 1.67 to 7.97), hemoglobin levels (HR: 0.75, 95% CI 0.64 to 0.89), age (HR: 1.04, 95% CI 1.02 to 1.06), CSF pleocytosis (HR: 0.34, 95% CI 0.14 to 0.84), and altered consciousness at admission (HR: 19.23, 95% CI 2.57 to 143.85).
TBM remains a critical concern with significant mortality and morbidity. Key predictors of mortality, including altered consciousness, hydrocephalus, and older age, highlight the need for early detection and tailored interventions. In most cases, the diagnosis cannot be definitively confirmed and is instead categorized as probable or possible. Our study demonstrates that survival rates were comparable across definite, probable, and possible TBM categories, supporting the value of empirical treatment when definitive confirmation is not feasible.
本研究旨在使用《柳叶刀》诊断确定性评分系统评估结核性脑膜炎(TBM)患者的临床特征、诊断确定性、预后及死亡预测因素。
对100例确诊为TBM的患者进行回顾性队列研究。根据《柳叶刀》评分系统将患者分为确诊、很可能、可能的TBM类别。分析临床特征、神经影像学表现、脑脊液(CSF)分析及预后情况。
患者中位年龄为36.5岁,男性占57.0%。最常见症状为发热(64.7%)、头痛(63.6%)和意识改变(60.0%)。40.0%的病例存在脑积水。诊断确定性分类为可能(63.0%)、很可能(22.0%)和确诊(15.0%)。住院死亡率为18.0%,12个月生存率为69.7%。诊断确定性水平与患者生存率之间无显著差异。死亡的显著预测因素包括脑积水(风险比[HR]:3.65,95%置信区间1.67至7.97)、血红蛋白水平(HR:0.75,95%置信区间0.64至0.89)、年龄(HR:1.04,95%置信区间1.02至1.06)、脑脊液细胞增多(HR:0.34,95%置信区间0.14至0.84)及入院时意识改变(HR:19.23,95%置信区间2.57至143.85)。
TBM仍然是一个严重问题,具有显著的死亡率和发病率。包括意识改变、脑积水和高龄在内的死亡关键预测因素凸显了早期检测及针对性干预的必要性。在大多数情况下,诊断无法得到明确证实,而是归类为很可能或可能。我们的研究表明,确诊、很可能和可能TBM类别患者的生存率相当,这支持了在无法进行明确证实时进行经验性治疗的价值。